Xiaoping Wang

7PUBLICATIONS
73CO-AUTHORS
Tumour immunologyRegenerative medicine (incl. stem cells)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 01, 2026
Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma.

|Sep 02, 2025
High-throughput assay confirmation of a T-cell receptor pre-mRNA fragment as a blood-based inflammatory breast cancer biomarker.

Elizabeth A Ferrick-Kiddie, Sriya Dommaraju, Jun Yao

|Oct 02, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.

Clinton Yam, Miral Patel, Holly A Hill

|Apr 17, 2024
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy.

Toshiaki Iwase, Evan N Cohen, Hui Gao

|Jul 03, 2023
TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma.

Dennis Wylie, Xiaoping Wang, Jun Yao

|Dec 16, 2022
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.

Xiaoping Wang, Takashi Semba, Ganiraju C Manyam

Pageof 2

Frequent Collaborators

7 joint publications

Naoto T Ueno

4 joint publications

Debu Tripathy

4 joint publications

Toshiaki Iwase

3 joint publications

Savitri Krishnamurthy